BeOne Medicines Ltd. (ONC)
364.02
+1.24
(+0.34%)
USD |
NASDAQ |
Oct 07, 16:00
354.00
-10.02
(-2.75%)
After-Hours: 07:31
BeOne Medicines Market Cap : 37.92B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 37.92B |
| October 06, 2026 | 37.79B |
| October 05, 2026 | 37.67B |
| October 02, 2026 | 37.30B |
| October 01, 2026 | 37.37B |
| September 30, 2026 | 38.12B |
| September 29, 2026 | 38.05B |
| September 28, 2026 | 38.23B |
| September 25, 2026 | 37.59B |
| September 24, 2026 | 37.50B |
| September 23, 2026 | 38.02B |
| September 22, 2026 | 38.34B |
| September 21, 2026 | 38.09B |
| September 18, 2026 | 36.55B |
| September 17, 2026 | 36.82B |
| September 16, 2026 | 36.26B |
| September 15, 2026 | 36.10B |
| September 14, 2026 | 36.86B |
| September 11, 2026 | 36.10B |
| September 10, 2026 | 35.61B |
| September 09, 2026 | 36.56B |
| September 08, 2026 | 36.61B |
| September 04, 2026 | 37.32B |
| September 03, 2026 | 37.78B |
| September 02, 2026 | 37.69B |
| Date | Value |
|---|---|
| September 01, 2026 | 37.36B |
| August 31, 2026 | 37.46B |
| August 28, 2026 | 38.20B |
| August 27, 2026 | 38.80B |
| August 26, 2026 | 39.15B |
| August 25, 2026 | 39.21B |
| August 24, 2026 | 38.75B |
| August 21, 2026 | 39.01B |
| August 20, 2026 | 38.46B |
| August 19, 2026 | 39.26B |
| August 18, 2026 | 38.45B |
| August 17, 2026 | 37.76B |
| August 14, 2026 | 36.20B |
| August 13, 2026 | 37.09B |
| August 12, 2026 | 37.40B |
| August 11, 2026 | 37.43B |
| August 10, 2026 | 37.40B |
| August 07, 2026 | 36.28B |
| August 06, 2026 | 34.36B |
| August 05, 2026 | 34.12B |
| August 04, 2026 | 33.65B |
| August 03, 2026 | 32.69B |
| July 31, 2026 | 32.32B |
| July 30, 2026 | 32.94B |
| July 29, 2026 | 33.46B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Basilea Pharmaceutica AG | 945.73M |
| Santhera Pharmaceuticals Holding AG | 274.57M |
| AC Immune SA | 234.13M |
| CRISPR Therapeutics AG | 5.060B |
| Idorsia Ltd. | 1.415B |
Market Cap Related Metrics
| PE Ratio | 63.97 |
| PS Ratio | 6.834 |
| Price to Book Value | 7.951 |
| Price to Free Cash Flow | 31.50 |
| Price | 364.02 |
| Earnings Yield | 1.56% |
| Operating PE Ratio | 45.38 |
| Normalized PE Ratio | 60.78 |